These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 17987061)

  • 41. Behavioral studies with anxiolytic drugs. I. Interactions of the benzodiazepine antagonist Ro 15-1788 with chlordiazepoxide, pentobarbital and ethanol.
    Barrett JE; Brady LS; Witkin JM
    J Pharmacol Exp Ther; 1985 Jun; 233(3):554-9. PubMed ID: 2989486
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Anxiolytic- and antidepressant-like properties of ketamine in behavioral and neurophysiological animal models.
    Engin E; Treit D; Dickson CT
    Neuroscience; 2009 Jun; 161(2):359-69. PubMed ID: 19321151
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The delta-opioid receptor agonist (+)BW373U86 regulates BDNF mRNA expression in rats.
    Torregrossa MM; Isgor C; Folk JE; Rice KC; Watson SJ; Woods JH
    Neuropsychopharmacology; 2004 Apr; 29(4):649-59. PubMed ID: 14647482
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A sensitive open field measure of anxiolytic drug activity.
    Britton DR; Britton KT
    Pharmacol Biochem Behav; 1981 Oct; 15(4):577-82. PubMed ID: 6117083
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Tuberoinfundibular peptide of 39 residues produces anxiolytic and antidepressant actions.
    LaBuda CJ; Dobolyi A; Usdin TB
    Neuroreport; 2004 Apr; 15(5):881-5. PubMed ID: 15073536
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The distribution of cannabinoid-induced Fos expression in rat brain: differences between the Lewis and Wistar strain.
    Arnold JC; Topple AN; Mallet PE; Hunt GE; McGregor IS
    Brain Res; 2001 Dec; 921(1-2):240-55. PubMed ID: 11720732
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Acute and sensitized response to 3,4-methylenedioxymethamphetamine in rats: different behavioral profiles reflected in different patterns of Fos expression.
    Colussi-Mas J; Schenk S
    Eur J Neurosci; 2008 Nov; 28(9):1895-910. PubMed ID: 18973603
    [TBL] [Abstract][Full Text] [Related]  

  • 48. 5-HT2C receptor desensitization moderates anxiety in 5-HTT deficient mice: from behavioral to cellular evidence.
    Martin CB; Martin VS; Trigo JM; Chevarin C; Maldonado R; Fink LH; Cunningham KA; Hamon M; Lanfumey L; Mongeau R
    Int J Neuropsychopharmacol; 2014 Oct; 18(3):. PubMed ID: 25522398
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Antidepressants attenuate both the enhanced ethanol intake and ethanol-induced anxiolytic effects in diazepam withdrawn rats.
    Martijena ID; Bustos SG; Bertotto ME; Molina VA
    Eur Neuropsychopharmacol; 2005 Jan; 15(1):119-30. PubMed ID: 15572281
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Preclinical characterization of ACH-000029, a novel anxiolytic compound acting on serotonergic and alpha-adrenergic receptors.
    Azevedo H; Ferreira M; Costa RW; Russo V; Russo E; Mascarello A; Guimarães CRW
    Prog Neuropsychopharmacol Biol Psychiatry; 2019 Dec; 95():109707. PubMed ID: 31330215
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Chronic treatment with antidepressants affects glycine/NMDA receptor function: behavioral evidence.
    Popik P; Wróbel M; Nowak G
    Neuropharmacology; 2000 Sep; 39(12):2278-87. PubMed ID: 10974311
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The mGlu5 receptor antagonist MPEP activates specific stress-related brain regions and lacks neurotoxic effects of the NMDA receptor antagonist MK-801: significance for the use as anxiolytic/antidepressant drug.
    Inta D; Filipovic D; Lima-Ojeda JM; Dormann C; Pfeiffer N; Gasparini F; Gass P
    Neuropharmacology; 2012 Apr; 62(5-6):2034-9. PubMed ID: 22261382
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects of intracerebroventricular ethanol on ingestive behavior and induction of c-Fos immunoreactivity in selected brain regions.
    Crankshaw DL; Briggs JE; Olszewski PK; Shi Q; Grace MK; Billington CJ; Levine AS
    Physiol Behav; 2003 Jun; 79(1):113-20. PubMed ID: 12818716
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of propranolol, buspirone, pCPA, reserpine, and chlordiazepoxide on open-field behavior.
    Angrini M; Leslie JC; Shephard RA
    Pharmacol Biochem Behav; 1998 Feb; 59(2):387-97. PubMed ID: 9476986
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The anxiolytics CI-988 and chlordiazepoxide fail to reduce immediate early gene mRNA stimulation following exposure to the rat elevated X-maze.
    Hinks GL; Brown P; Field M; Poat JA; Hughes J
    Eur J Pharmacol; 1996 Sep; 312(2):153-61. PubMed ID: 8894590
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cellular mechanisms underlying the anxiolytic effect of low doses of peripheral Delta9-tetrahydrocannabinol in rats.
    Rubino T; Sala M; Viganò D; Braida D; Castiglioni C; Limonta V; Guidali C; Realini N; Parolaro D
    Neuropsychopharmacology; 2007 Sep; 32(9):2036-45. PubMed ID: 17287821
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Anxiolytic potential of a microgram dose of chlordiazepoxide in the open-field test.
    Bruhwyler J
    Eur J Pharmacol; 1990 Oct; 187(3):547-9. PubMed ID: 1981557
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pharmacology of neuropeptide S in mice: therapeutic relevance to anxiety disorders.
    Leonard SK; Dwyer JM; Sukoff Rizzo SJ; Platt B; Logue SF; Neal SJ; Malberg JE; Beyer CE; Schechter LE; Rosenzweig-Lipson S; Ring RH
    Psychopharmacology (Berl); 2008 May; 197(4):601-11. PubMed ID: 18311561
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Environmental novelty differentially affects c-fos mRNA expression induced by amphetamine or cocaine in subregions of the bed nucleus of the stria terminalis and amygdala.
    Day HE; Badiani A; Uslaner JM; Oates MM; Vittoz NM; Robinson TE; Watson SJ; Akil H
    J Neurosci; 2001 Jan; 21(2):732-40. PubMed ID: 11160452
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Induction of Fos-like proteins and ultrasonic vocalizations during ethanol withdrawal: further evidence for withdrawal-induced anxiety.
    Knapp DJ; Duncan GE; Crews FT; Breese GR
    Alcohol Clin Exp Res; 1998 Apr; 22(2):481-93. PubMed ID: 9581657
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.